Capnia Inc Share Price Nasdaq
Equities
US14066L1052
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
06-06 | Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call | |
06-04 | Soleno Therapeutics to Join Russell 3000 Index | MT |
Sales 2024 * | - | Sales 2025 * | 44.75M 3.5B | Capitalization | 1.63B 127B |
---|---|---|---|---|---|
Net income 2024 * | -96M -7.51B | Net income 2025 * | -66M -5.16B | EV / Sales 2024 * | - |
Net cash position 2024 * | 238M 18.62B | Net cash position 2025 * | 151M 11.83B | EV / Sales 2025 * | 32.9 x |
P/E ratio 2024 * |
-17.6
x | P/E ratio 2025 * |
-28.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.68% |
Latest transcript on Capnia Inc
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 31/12/05 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 13/11/19 |
Ernest Mario
CHM | Chairman | 85 | 02/08/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 02/08/07 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 25/04/19 |
Bill Harris
BRD | Director/Board Member | 65 | 01/06/14 |
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |